Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Predicts Cardiovascular Risk After Ischemic Attack

By MedImaging International staff writers
Posted on 19 Aug 2009
Ultrasound can be used to determine a patient's heart risk after a transient ischemic attack (TIA). An evaluation of transcranial (TCD) and extracranial (ECD) Doppler ultrasonography has shown that both future stroke and future cardiovascular ischemic events can be predicted by abnormal findings.

Cardiovascular disease is the major cause of death on long-term follow-up after a TIA. Dr. Holger Poppert, from the Technische Universität München (Munich, Germany), worked with a team of researchers to evaluate the ability of ultrasound to predict the likelihood of new vascular events in 176 TIA patients, with a median follow-up of 27 months. He said, "Nearly 40% of the patients with either steno-occlusive disease in ECD or pathological findings in TCD suffered a new ischemic stroke or TIA. Furthermore, detection of reactive collateral flow patterns or intracranial stenosis by TCD predicts new cardiovascular ischemic events on medium to long-term follow-up.”

The researchers found that 5 of 18 patients with abnormal TCD findings (27.8%), but only 4 of 134 patients without (3%), developed a subsequent cardiovascular ischemic event. Speaking about these results, Dr. Poppert said, "Our findings support the routine use of TCD in addition to ECD in TIA patients. Moreover, routine screening tests for coronary artery disease and aggressive prevention therapies should be considered in TIA patients with pathological TCD findings.”

The study was published July 30, 2009, the open access journal BMC Medical Imaging

Related Links:

Technische Universität München


Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Post-Processing Imaging System
DynaCAD Prostate
Half Apron
Demi
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.